Utah Medical Products, Inc. (UTMD)

NASDAQ: UTMD · Real-Time Price · USD

72.23

+1.19 (1.68%)

At close: Nov 6, 2026, 4:00 PM EST

71.99

-0.24 (-0.33%)

After-hours: Nov 6, 2026, 7:43 PM EST

Utah Medical Products Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	34.92	38.52	40.9	50.22	52.28	49.05
Revenue Growth	-9.62%	-5.83%	-18.56%	-3.94%	6.58%	16.30%
Cost of Revenue	14.77	16.52	16.76	20.19	20.09	18.14
Gross Profit	20.14	22	24.14	30.04	32.2	30.92
Selling, General & Admin	7.52	8.58	7.6	12.7	11.91	11.51
Research & Development	0.66	0.67	0.81	0.56	0.49	0.53
Operating Expenses	8.18	9.24	8.41	13.26	12.41	12.04
Operating Income	11.97	12.76	15.73	16.78	19.79	18.88
Interest & Investment Income	2.81	2.81	3.37	3.04	0.66	0.17
Currency Exchange Gain (Loss)	-0.02	-0.02	0	-	-	-
Other Non Operating Income (Expenses)	-0.27	-0.08	-0.16	0.28	0.21	0.02
EBT Excluding Unusual Items	14.49	15.47	18.94	20.09	20.66	19.06
Legal Settlements	-1.52	-1.36	-2.14	-	-	-
Pretax Income	12.98	14.11	16.8	20.09	20.66	19.06
Income Tax Expense	2.33	2.82	2.93	3.45	4.19	4.27
Net Income	10.64	11.29	13.87	16.64	16.47	14.79
Net Income to Common	10.64	11.29	13.87	16.64	16.47	14.79
Net Income Growth	-8.42%	-18.65%	-16.60%	0.98%	11.39%	36.95%
Shares Outstanding (Basic)	3	3	4	4	4	4
Shares Outstanding (Diluted)	3	3	4	4	4	4
Shares Change	-3.07%	-7.51%	-3.68%	-0.17%	-0.46%	-0.33%
EPS (Basic)	3.34	3.48	3.96	4.58	4.53	4.05
EPS (Diluted)	3.34	3.48	3.96	4.57	4.52	4.04
EPS Growth	-5.56%	-12.06%	-13.33%	1.11%	11.88%	37.41%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-	14.32	14.6	21.64	20.34	20.65
Free Cash Flow Per Share	-	4.42	4.17	5.95	5.58	5.64
Dividend Per Share	0.310	1.225	1.205	1.185	1.165	0.855
Dividend Growth	-74.59%	1.66%	1.69%	1.72%	36.26%	-23.66%
Gross Margin	57.69%	57.12%	59.03%	59.81%	61.58%	63.03%
Operating Margin	34.27%	33.12%	38.46%	33.40%	37.85%	38.49%
Profit Margin	30.48%	29.30%	33.92%	33.12%	31.51%	30.15%
Free Cash Flow Margin	-	37.18%	35.70%	43.09%	38.90%	42.10%
EBITDA	13.39	15.71	18.53	23.09	26.82	26.16
EBITDA Margin	38.34%	40.78%	45.30%	45.98%	51.30%	53.33%
D&A For EBITDA	1.42	2.95	2.8	6.32	7.03	7.28
EBIT	11.97	12.76	15.73	16.78	19.79	18.88
EBIT Margin	34.27%	33.12%	38.46%	33.40%	37.85%	38.49%
Effective Tax Rate	17.98%	20.01%	17.43%	17.19%	20.26%	22.42%

SEC Filings: 10-K · 10-Q